| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/16/1991 | WO1991006283A1 Tissue moisturizing composition and method |
| 05/15/1991 | EP0427680A1 Heteroatoms-containing tricyclic compounds |
| 05/14/1991 | US5015631 Repair for mucous membranes for nasal obstructions |
| 05/14/1991 | CA2027604A1 N-substituted derivatives of 3r, 4r-ethyl- ((1-methyl-1h-imidazol-5-yl)methyl)-2-pyrrolidinone |
| 05/14/1991 | CA2027602A1 Pharmaceutical epinephrine-pilocarpine derivatives |
| 05/08/1991 | EP0426390A2 Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure |
| 05/08/1991 | EP0362321A4 Ophthalmic suspensions |
| 05/02/1991 | WO1991005537A1 Method of accelerating wound and ulcer healing and treating periodontal disease |
| 05/02/1991 | EP0425211A1 Substituted 5-((tetrazolyl)alkenyl)-imidazoles |
| 05/01/1991 | CA2025189A1 Method for using (2-imidazolin-2-ylamino)quinoxalines to reduce or maintain intraocular pressure |
| 04/30/1991 | US5011856 Side effect reduction |
| 04/30/1991 | US5011844 Substituted 4-azatricyclo(22.3.1.04,9)octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them |
| 04/30/1991 | US5011840 Imidazolidinedione derivatives in diabetes treatment |
| 04/30/1991 | US5011839 3(2H)pyridazinones for antagonistic agent against srs-a |
| 04/26/1991 | CA2027937A1 Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles |
| 04/24/1991 | EP0424043A1 Liquid aqueous ophthalmic composition undergoing liquid-gel phase transition |
| 04/23/1991 | US5010204 Glaucoma treatment |
| 04/18/1991 | WO1991004741A1 Composition for the treatment of progressive myopia |
| 04/17/1991 | EP0422878A1 (2-Imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 04/17/1991 | EP0422681A1 Collagen containing ophthalmic formulation |
| 04/17/1991 | EP0422666A2 6-Substituted-1,2,3,4-tetrahydroisoquinolines |
| 04/17/1991 | EP0422181A1 Method and means for inducing, resp., preventing constriction of the pupil in the eye |
| 04/17/1991 | EP0422079A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use |
| 04/16/1991 | US5008283 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 04/16/1991 | US5008242 Treatment of inflammation using 1-antichymotrypsin |
| 04/14/1991 | CA2027433A1 Collagen containing ophthalmic formulation |
| 04/14/1991 | CA2027325A1 6-substituted-1,2,3,4-tetrahydroisoquinolines |
| 04/10/1991 | EP0421365A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
| 04/09/1991 | CA1282704C Ocular antihypertensive composition for topical use |
| 04/04/1991 | WO1991000100A3 Toxin uses |
| 04/03/1991 | EP0420798A1 Antimicrobial compositions |
| 04/03/1991 | EP0420606A2 Use of 2-cycloalkylamino oxazolines for reducing or maintaining intraocular pressure |
| 04/03/1991 | EP0420064A2 Substituted 2-amidotetralins as melatonin agonists and antagonists |
| 04/03/1991 | CN1050385A Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
| 04/02/1991 | US5004743 Antiinflammatory, cytoprotective agents |
| 04/02/1991 | CA1282334C 2-¬(3,5-dihalo-4-aminobenzyl)| imidazolines |
| 03/27/1991 | EP0419311A2 Prodrugs of carbonic anhydrase inhibitors |
| 03/27/1991 | EP0419132A2 Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 03/27/1991 | EP0419131A2 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 03/27/1991 | EP0419048A2 Substituted pyrimidinones as angiotensin II antagonists |
| 03/27/1991 | EP0418597A2 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| 03/27/1991 | EP0418230A1 Method for potentiating and inhibiting insulin-like growth factor activity. |
| 03/26/1991 | CA2025958A1 Substituted 2-amidotetralins as melatonin agonists and antagonists |
| 03/23/1991 | CA2024421A1 Prodrugs of carbonic anhydrase inhibitors |
| 03/22/1991 | CA2025763A1 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| 03/21/1991 | WO1991003245A1 Ophthalmic composition |
| 03/20/1991 | EP0341264A4 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 03/20/1991 | CA2023813A1 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4 - tetrahydroquinolinyl group having retinoid-like activity |
| 03/19/1991 | US5001153 Ocular hypotensive agents |
| 03/19/1991 | US5001132 Phenyloxypropanolamine derivatives and their application in therapeutics |
| 03/19/1991 | US5001117 Use of lecithin to restore olfaction and taste |
| 03/19/1991 | CA1281653C Opthlamic use of quinolone and napththyridine antibiotics |
| 03/19/1991 | CA1281650C Aqueous preparation containing cyclodextrin |
| 03/13/1991 | EP0416925A2 Use of 4-hydroxy-alpha 1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol or its salts in the treatment of allergy and inflammation |
| 03/13/1991 | EP0416609A2 Benzo[b]thiophene-containing lipoxygenase-inhibiting compounds |
| 03/12/1991 | US4999367 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids, compositions and use |
| 03/07/1991 | WO1991002527A1 Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists |
| 03/07/1991 | CA2065375A1 Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists |
| 03/01/1991 | CA2024113A1 Substituted pyrimidinones as angiotensin ii antagonists |
| 02/27/1991 | EP0414373A2 Stable solution of hyaluronate in a balanced salt medium |
| 02/26/1991 | US4996318 Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke |
| 02/26/1991 | US4996218 Chloroaniline derivatives |
| 02/26/1991 | US4996204 Antidiabetic agents |
| 02/20/1991 | EP0413433A1 Isoindolyl-imidazole-derivatives and pharmaceutical compositions |
| 02/20/1991 | EP0413329A2 5-Methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases |
| 02/19/1991 | US4994274 Treating glaucoma |
| 02/13/1991 | EP0412641A2 Use of vitamin D in retinopathy |
| 02/13/1991 | EP0412594A2 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists |
| 02/12/1991 | US4992468 Treatment of skin disorders |
| 02/06/1991 | EP0411766A1 Substituted quinazolinones as angiotensin II antagonists |
| 02/06/1991 | EP0411704A1 Substituted aromatic sulfonamides as antiglaucoma agents |
| 02/06/1991 | EP0411702A1 4-(2-methyl-2-hydroxypropyl-amino)-5,6-dihydrothieno-2(2,3-B)thiopyran-2-sulfonamide-7,7-dioxide |
| 02/06/1991 | CN1048980A Intraocular pressure reducing 11, 15-diacyl prostaglandins |
| 02/05/1991 | CA1279824C Pharmaceutical and dietary composition containing -linolenic acid |
| 02/01/1991 | WO1991001725A1 A NOVEL USE OF β-RECEPTOR BLOCKING AGENTS FOR TREATMENT OF MENIERES' DISEASE |
| 02/01/1991 | CA2022118A1 4-(2-methyl-2-hydroxypropylamino)-5,6-dihydrothieno-[2,3-b] thiopyran-2-sulfonamide-7,7-dioxide |
| 01/30/1991 | EP0410801A2 Intraocular pressure reducing 9,15-diacyl prostaglandins |
| 01/30/1991 | EP0410787A2 Intraocular pressure reducing 9,11-diacyl prostaglandins |
| 01/30/1991 | EP0410786A1 Intraocular pressure reducing 11,15-diacyl prostaglandins |
| 01/30/1991 | EP0410785A2 Intraocular pressure reducing 11-acyl prostaglandins |
| 01/30/1991 | EP0410749A2 Anthocyanidins for the treatment of ophthalmic diseases |
| 01/30/1991 | EP0410742A1 Phenylethenyl compounds having retinoid-like activity |
| 01/30/1991 | EP0410006A1 Eye drops for healing wound of corneal epithelium |
| 01/29/1991 | US4988733 N-[1-(3-phenoxyphenyl)ethyl]acetohydroxamic acid compounds which are useful anti-inflammatory agents |
| 01/28/1991 | CA2020254A1 Intraocular pressure reducing 9, 15-diacyl prostaglandins |
| 01/28/1991 | CA2020252A1 Intraocular pressure reducing 11, 15-diacyl prostaglandins |
| 01/27/1991 | CA2020253A1 Phenylethenyl compounds having retinoid-like activity |
| 01/23/1991 | EP0409729A1 Bi-aromatic thioesters, process for their preparation and their use in human or veterinary medicine and in cosmetics |
| 01/23/1991 | EP0409728A2 Bi-aromatic esters, process for their preparation and their use in human or animal medicine and in cosmetics |
| 01/23/1991 | EP0409662A2 Zinc spray preparations |
| 01/23/1991 | EP0409332A2 Substituted triazoles as angiotensin II antagonists |
| 01/20/1991 | CA2021255A1 Substituted triazoles as angiotensin ii antagonists |
| 01/19/1991 | CA2021330A1 Di-aromatic thioesters, process for their preparation and their use in human and veterinary medicine and as cosmetic composition |
| 01/16/1991 | CN1048546A Substituted imidazo-fused 6-membered heterocycles as angiotensin ii antagonists |
| 01/16/1991 | CN1048496A Aqueous liquid composition for external use |
| 01/15/1991 | WO1991001333A1 Methods of treating or preventing autoimmune uveoretinitis in mammals |
| 01/15/1991 | US4985462 Alicyclic compounds and their contraceptive use |
| 01/15/1991 | US4985417 Treatment of glaucoma |
| 01/15/1991 | US4985407 Renin Inhibitors, Treating Cardiovascular Disorders, Hypotensive Agents |
| 01/15/1991 | CA1279015C Increasing aqueous humor outflow |